Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions.
about
Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivoPlasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors.Serpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritisEvaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban.Preserved arterial vasodilatation via endothelial protease-activated receptor-2 in obese type 2 diabetic miceThe Interface between Inflammation and Coagulation in Cardiovascular Disease.Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.Increased expression of protease-activated receptor-2 in mucosal mast cells in Crohn's ileitis.Protease-Activated Receptor 2 Promotes Pro-Atherogenic Effects through Transactivation of the VEGF Receptor 2 in Human Vascular Smooth Muscle Cells.Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice.Protease-activated receptor-2 (PAR(2)) in human periodontitis.Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells.Porphyromonas gingivalis is associated with protease-activated receptor-2 upregulation in chronic periodontitis.
P2860
Q28511351-10B6352C-4707-4650-9A47-35D0068B92FBQ34251521-0BD03016-AB68-4B68-87AE-EA2DFD6399BFQ35058267-FA01C306-A45F-40BB-9540-D8A304345635Q35099133-2C3BAAEB-B445-45A9-BA01-FAE9475349BBQ35216480-50029D6C-4E61-4E3C-98AF-14B6DF665BB3Q35821321-B87C3FED-3151-4562-B6C8-7B95E402BA11Q37216583-458CB73C-8347-4CD1-87D0-7DA4111DFD57Q39845444-89B159FE-46BB-4891-8C64-3F3D5DDF1F7AQ40630385-A2F6EFC8-CDFF-426F-8965-D8EFE0BF5459Q41673298-29452D13-AA30-49AC-9978-204043441471Q43041555-AB679489-38F1-462F-B48D-C8044E1D0118Q47154353-87AECE4F-CD20-4B05-888D-4E4D5743F800Q54376497-77AF8C67-8E36-4D35-ADB4-664A74827E45
P2860
Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Evidence that protease activat ...... onary atherosclerotic lesions.
@en
Evidence that protease activat ...... onary atherosclerotic lesions.
@nl
type
label
Evidence that protease activat ...... onary atherosclerotic lesions.
@en
Evidence that protease activat ...... onary atherosclerotic lesions.
@nl
prefLabel
Evidence that protease activat ...... onary atherosclerotic lesions.
@en
Evidence that protease activat ...... onary atherosclerotic lesions.
@nl
P2093
P2860
P50
P356
P1476
Evidence that protease activat ...... ronary atherosclerotic lesions
@en
P2093
J L Wallace
M D Hollenberg
P2860
P304
P356
10.1136/JCP.2003.015156
P407
P577
2004-05-01T00:00:00Z